| Lastest Insider Transactions Of Viracta Therapeutics, Inc. ( VIRX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | Directior | 2024-11-25 | Option Exercise | 25,219 | 0.00 | 0 | 2024-11-27 16:08:36 |
| VIRX | Viracta Therapeutics, Inc. | Pomerantz Roger | Directior | 2024-11-25 | Option Exercise | 9,034 | 0.00 | 0 | 2024-11-27 16:06:38 |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | Directior | 2024-08-25 | Option Exercise | 25,219 | 0.00 | 0 | 2024-09-12 18:13:15 |
| VIRX | Viracta Therapeutics, Inc. | Pomerantz Roger | Directior | 2024-08-25 | Option Exercise | 9,034 | 0.00 | 0 | 2024-09-12 18:10:04 |
| VIRX | Viracta Therapeutics, Inc. | Pomerantz Roger | Directior | 2024-05-25 | Option Exercise | 9,035 | 0.00 | 0 | 2024-05-29 19:12:33 |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | Directior | 2024-05-25 | Option Exercise | 25,219 | 0.00 | 0 | 2024-05-29 19:07:46 |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | Directior | 2024-02-25 | Option Exercise | 25,219 | 0.00 | 0 | 2024-02-27 19:58:56 |
| VIRX | Viracta Therapeutics, Inc. | Pomerantz Roger | Directior | 2024-02-25 | Option Exercise | 9,034 | 0.00 | 0 | 2024-02-27 19:56:59 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2024-02-25 | Sell | 3,405 | 0.73 | 2,493 | 2024-02-27 19:54:13 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2024-02-25 | Option Exercise | 6,889 | 0.00 | 0 | 2024-02-27 19:54:13 |
| VIRX | Viracta Therapeutics, Inc. | Rothera Mark | President and CEO | 2023-11-30 | Buy | 100,000 | 0.49 | 49,362 | 2023-12-04 16:54:41 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2023-11-25 | Sell | 3,720 | 0.50 | 1,860 | 2023-11-28 19:06:17 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2023-11-25 | Option Exercise | 6,889 | 0.00 | 0 | 2023-11-28 19:06:17 |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | Directior | 2023-11-25 | Option Exercise | 25,219 | 0.00 | 0 | 2023-11-28 19:03:27 |
| VIRX | Viracta Therapeutics, Inc. | Pomerantz Roger | Directior | 2023-11-25 | Option Exercise | 9,034 | 0.00 | 0 | 2023-11-28 19:01:32 |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | Directior | 2023-08-25 | Option Exercise | 25,219 | 0.00 | 0 | 2023-08-29 18:52:54 |
| VIRX | Viracta Therapeutics, Inc. | Pomerantz Roger | Directior | 2023-08-25 | Option Exercise | 9,034 | 0.00 | 0 | 2023-08-29 18:49:58 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2023-08-25 | Sell | 3,512 | 1.45 | 5,092 | 2023-08-29 18:47:04 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2023-08-25 | Option Exercise | 6,888 | 0.00 | 0 | 2023-08-29 18:47:04 |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | Directior | 2023-05-25 | Option Exercise | 25,219 | 0.00 | 0 | 2023-05-26 19:32:29 |
| VIRX | Viracta Therapeutics, Inc. | Pomerantz Roger | Directior | 2023-05-25 | Option Exercise | 9,035 | 0.00 | 0 | 2023-05-26 19:30:50 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2023-05-25 | Sell | 3,635 | 1.42 | 5,160 | 2023-05-26 19:29:02 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2023-05-25 | Option Exercise | 6,889 | 0.00 | 0 | 2023-05-26 19:29:02 |
| VIRX | Viracta Therapeutics, Inc. | ROYSTON IVOR | Directior | 2023-02-25 | Option Exercise | 25,219 | 0.00 | 0 | 2023-02-28 18:30:33 |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | 2023-02-25 | Sell | 2,156 | 1.68 | 3,625 | 2023-02-28 18:28:28 |
| VIRX | Viracta Therapeutics, Inc. | Rojkjaer Lisa | Chief Medical Officer | 2023-02-25 | Option Exercise | 4,127 | 0.00 | 0 | 2023-02-28 18:28:28 |
| VIRX | Viracta Therapeutics, Inc. | Pomerantz Roger | Directior | 2023-02-25 | Option Exercise | 9,034 | 0.00 | 0 | 2023-02-28 18:25:29 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2023-02-25 | Sell | 3,599 | 1.68 | 6,051 | 2023-02-28 18:22:56 |
| VIRX | Viracta Therapeutics, Inc. | Chevallard Daniel R. | CFO and COO | 2023-02-25 | Option Exercise | 6,889 | 0.00 | 0 | 2023-02-28 18:22:56 |
